GlyCulator2: an update on a web application for calculation of glycemic variability indices
Continuous glucose monitoring (CGM) was shown to be clinically useful in improving treatment of type 1 and type 2 diabetes . The clinical benefits of CGM are numerous, but in essence, the additional insight into short-term glucose fluctuations may, if properly interpreted by the patient, limit the number of hypoglycemic episodes, reduce average blood glucose concentration and lower HbA1c levels . However, apart from these indices, CGM enables the patients and their doctors to evaluate glycemic variability (GV) with unprecedented detail and make clinical judgments on the characteristics of the CGM changes quantified using multiple methodologies. The debate on the feasibility of using GV indices in clinical decision making process has been ongoing  and was hindered by the lack of clear guidelines for the manner of reporting and interpreting GV. Prompted by the publication of the International Consensus On Use of Continuous Glucose Monitoring , which specified the...
KeywordsContinuous glucose monitoring Glycemic variability Glycemic variability calculator
Konrad Pagacz and Wojciech Fendler were supported by the First TEAM project funded by Smart Growth Operational Programme and the Foundation for Polish Science. Konrad Pagacz was supported by Medical University of Lodz's “Grants of UMED”.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
Human and animal rights
This article does not contain any studies with human or animal subjects performed by any of the authors.
Informed consent for blinded data analysis was obtained from all patients undergoing CGM as part of their routine monitoring.